A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety, and Tolerability of Chondroitin Sulfate 800 mg Tablets Versus Placebo in Subjects With Pain Due to Knee Osteoarthritis and to Evaluate the Durability of the Effect and Safety of the Treatment
Latest Information Update: 10 Oct 2023
At a glance
- Drugs Chondroitin sulfate (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms MOTION
- Sponsors IBSA
Most Recent Events
- 03 Oct 2023 Planned End Date changed from 1 Apr 2025 to 1 Jul 2026.
- 03 Oct 2023 Planned primary completion date changed from 1 Oct 2024 to 1 Dec 2025.
- 03 Oct 2023 Planned initiation date changed from 1 Apr 2023 to 1 Dec 2023.